PETER HITCHENS: ADHD is a fake diagnosis that doesn't exist. I see exactly where this pandemic of idiocy is leading us all...
'My heart is sick and sad. From where the sun stands today, I shall fight no more forever,' as the great Chief Joseph of the Nez Perce nation so beautifully expressed it in 1877, after a noble 1,300-mile fighting retreat in face of the US Army.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
8 minutes ago
- The Independent
The drink with opioid-like effects being sold over the counter
Social media users and experts are warning about the opioid-like substance kratom, found in products like Feel Free tonics, which are increasingly available in various retail outlets. The Food and Drug Administration has cautioned against kratom's use for self-treatment and its potential for abuse, with addiction medicine specialists reporting numerous cases of dependency. Personal accounts, including viral TikTok videos, highlight severe addiction to Feel Free tonics, with one user detailing hospitalisation due to withdrawal symptoms. Botanic Tonics, Feel Free's maker, denies widespread addiction claims. In 2023, it settled an $8.75 million lawsuit for failing to warn consumers about kratom's risks but did not admit wrongdoing by settling the lawsuit. While the FDA recommends controlling a concentrated kratom byproduct, natural kratom leaf products are unaffected; however, rare deaths have been associated with kratom, including a case where a family attributes their son's death to it.
Reuters
2 hours ago
- Reuters
GSK's antibiotic gets FDA priority review for oral treatment of gonorrhoea
Aug 11 (Reuters) - British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority review of gepotidacin, an oral antibiotic to treat sexually transmitted uncomplicated gonorrhoea. GSK is counting on new infectious disease treatments, such as its recently launched respiratory syncytial virus vaccine, to help offset revenue losses from its top-selling drugs and anticipated patent expirations for its HIV therapies. The drug gepotidacin has already been approved in the United States under the brand name Blujepa for a common type of urinary tract infection (UTI) in women and adolescent girls. The FDA's decision on the drug's treatment of uncomplicated urogenital gonorrhoea is expected in December. If approved, it would provide an oral option to patients who currently rely on injectable treatments.
Reuters
3 hours ago
- Reuters
GSK's antibiotic drug gepotidacin gets priority review by FDA
Aug 11 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Monday its supplemental new drug application for antibiotic drug gepotidacin has been accepted for priority review by the U.S. Food and Drug Administration for the oral treatment of uncomplicated urogenital gonorrhoea.
